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ABSTRACT
Objective: The main objective of the present study was to investigate the ameliorative potential of synthetic antioxidants mixture comprising N-acetyl 
cysteine, ascorbic acid, tocopheryl acetate, and thiamine as micronutrient combinational therapy and ethanolic extract of Bacopa monnieri as herbal 
antioxidant therapy approach against lead toxicity-induced metabolic dysfunctions in vitro.
Methods: Experimental study involved in vitro exposure of mice brain and liver homogenates to different doses (100 μM, 250 μM, and 500 μM) of 
lead acetate. The study also involved coadministration of high-dose lead acetate (500 μM) and specific dosage of synthetic antioxidants or ethanolic 
extract of B. monnieri separately to homogenate cultures. Alterations in metabolic parameters of protein levels and lipid peroxidation were analyzed 
for evaluating the protective effect of synthetic antioxidants and B. monnieri against lead intoxication.
Results: Results revealed dose-dependent statistically significant (p<0.001) reduction in protein levels and elevation in lipid peroxidation in lead 
acetate exposed mice brain and liver homogenates as compared to their respective control groups. Coadministration of lead acetate and synthetic 
antioxidants mixture or B. monnieri in the brain and liver homogenates conferred protection and manifested maintenance of studied biochemical 
parameters nearest to control groups. Ameliorative efficacy of B. monnieri against lead-induced neurotoxicity and hepatotoxicity was found to be more 
pronounced than that of a mixture of synthetic antioxidants.
Conclusion: Synthetic antioxidants mixture (N-acetyl cysteine, ascorbic acid, tocopheryl acetate, and thiamine) and B. monnieri exhibited remarkable 
therapeutic efficacy against lead toxicity-induced metabolic dysfunctions in mice brain and liver homogenates by virtue of their antioxidant, 
neuroprotective, and hepatoprotective abilities.
Keywords: Lead toxicity, Neurotoxicity, Hepatotoxicity, Synthetic antioxidants, Bacopa monnieri, Neuroprotective activity, Hepatoprotective activity, 
Amelioration, Metabolism.
INTRODUCTION
Lead metal is considered as one of the most pervasive and dreaded 
occupational and environmental toxicants of global concern. On the 
criteria of the occurrence frequency of toxicological consequences and 
human exposure potential, Agency for Toxic Substances and Disease 
Registry has placed lead metal at the second position in the priority list 
of “top 20 hazardous substances” [1].
Lead compounds are employed indiscriminately in the industries 
for manufacturing of lead-acid batteries, cosmetics, paints, weights, 
toys, kitchen utensils, ayurvedic medicines, lead pipes, ammunitions, 
and radiation shields due to their cost-effectiveness and easy 
availability [2]. Non-biodegradable nature of lead facilitates its entry 
into the food chain resulting in its bio-magnification. Lead accumulation 
in experimental animal and human tissues has been found to be 
associated with considerable health risks due to its tendency to induce 
a broad range of physiological and biochemical dysfunctions [3,4]. 
Lead has been well documented as a cumulative metabolic poison at 
higher concentrations [5]. Lead exposure has the propensity to induce 
alterations in mammalian metabolism due to its potent systemic toxicity. 
Lead exposure has been associated with triggering of detrimental 
effects on the nervous system [6-8], hemopoietic system [9], hepatic 
system [10,11], and reproductive system [12].
Clinical manifestation of lead toxicity can be observed in multiple organs. 
The most deceptive form of lead toxicity is that affecting the nervous 
system as brain is the prime accumulator of inorganic lead. Lead has been 
reported as a potent neurotoxin, and it particularly affects the developing 
nervous system [7]. Exposure to even low levels of lead is associated 
with behavioral abnormalities, hearing impairment, learning disabilities, 
and cognitive dysfunctions in experimental animals as well as human 
beings [13,14]. Liver is the most frequent target organ for this metallic 
toxicant. It has been reported as the largest repository of lead (33%) 
per g of wet tissue among the soft tissues followed by kidney cortex and 
medulla in humans [15]. Lead-induced hepatotoxicity is of major concern 
because liver plays a key role in carbohydrate metabolism, protein 
metabolism, lipid metabolism, energy production, and detoxification of 
xenobiotics [16]. Lead exposure has been reported to cause infiltration 
of lymphocytes, liver cirrhosis, and disruption of liver structure as well as 
functions [17,18]. Hence, lead-induced neurotoxicity and hepatotoxicity 
mediated alterations in metabolic functions can be considered as one of 
the major issues of public health concern.
Keeping this perspective in view, present in vitro study was intended 
with the objective to elucidate the underlying deleterious mechanism 
of oxidative stress resulted due to lead intoxication through exploration 
of metabolic alterations in protein levels and lipid peroxidation in mice 
brain as well as liver homogenate cultures. To overcome lead-induced 
oxidative stress resulted due to pro-oxidant/antioxidant imbalance 
within mammalian tissues; a therapeutic strategy of exogenous 
supplementation of antioxidants can be beneficial. Antioxidants can 
also act as strong metal chelating agents and mobilize metals from hard 
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2019.v12i4.31851
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and soft tissues. These multifaceted benefits of antioxidants make them 
strong ameliorative agents to be utilized clinically as antidotes for the 
treatment of lead poisoning. Considering this facet, another objective of 
the present in vitro study was to explore ameliorative efficacy of synthetic 
antioxidants such as N-acetyl cysteine, ascorbic acid, tocopheryl acetate, 
and thiamine in a novel mixture to exert synergistic effect against 
lead-induced neurotoxic and hepatotoxic metabolic dysfunctions as 
combinational therapy approach which had not been worked out earlier. 
In addition, there is a paucity of knowledge regarding herbal antioxidants 
with maximum cost-effectiveness and minimum side effects that can act 
as ameliorative agents against lead toxicity. Bacopa monnieri (Brahmi) 
is a traditional ayurvedic plant belonging to the Scrophulariaceae family 
with a wide spectrum of pharmacological properties. Keeping this 
perspective, the other major objective of present study was to investigate 
the possible ameliorative potential of medicinal plant B. monnieri as a 
novel neuroprotective and hepatoprotective agent against lead toxicity-
induced metabolic dysfunctions in mammalian tissues.
METHODS
Chemicals
All the chemicals utilized in the present research work were analytical 
grade reagents (AR). Lead acetate trihydrate, N-Acetyl cysteine 
(NAC), ascorbic acid (Vitamin-C), tocopheryl acetate (Vitamin-E), 
thiamine (Vitamin-B1), and other chemicals having 99% purity used 
in the present study were purchased from HiMedia, Sigma and Merck 
Laboratory Pvt., Ltd., India.
Preparation of lead acetate and antioxidants reagents
About 10 mM stock solution of lead acetate was prepared in doubled 
distilled water. A definite volume of this stock solution was utilized in a final 
volume of the reaction mixture, so as to get the required concentrations 
of 100 μM, 250 μM, and 500 μM lead acetate dosage. N-Acetyl cysteine, 
ascorbic acid, thiamin, B. monnieri extract, and other reagents employed 
for in vitro assays in the present study were dissolved in double distilled 
water. Tocopheryl acetate was administered directly in the form of Evion-
emulsion syrup after purchasing from Merck Laboratory.
Preparation of the ethanolic extract of B. monnieri
Creeper plant B. monnieri was collected from Botanical Garden of 
University School of Sciences, Gujarat University, Ahmedabad, India, 
during December. The plant was identified and authenticated by Botany 
Department of the University with a voucher specimen submitted to 
the herbarium. The whole plant of B. monnieri was thoroughly washed 
with double distilled water and cut into small pieces. Plant material 
was dried in the shade in dust free condition for the period of 1 week 
at room temperature and finally ground to coarse powder. 10 g of 
powdered whole plant material was mixed with 100 ml of 90% ethanol 
as solvent and subjected to Soxhlet extraction at 78°C for 11-hrs. The 
resultant crude extract was concentrated, air-dried and stored at 20°C 
in a dark bottle for further use.
Experimental animals
Fresh mice brain and liver tissues were utilized as mammalian vital organs 
for the preparation of homogenate cultures in the present in vitro study. 
The main purpose of in vitro experimental design was the minimization 
of animal usage. Healthy male Swiss albino mice (Mus musculus) of 
4–5 weeks of age and weighing about 30–35 g were obtained from 
Cadila Pharmaceuticals, Dholka, India, under Animal Maintenance and 
Registration No. 167/1999/CPCSEA obtained from the Ministry of Social 
Justice and Empowerment, Government of India. Animals were caged 
separately in the animal house of Gujarat University as per guidelines of 
Committee for the Purpose of Control and Supervision of Experiments on 
Animals (CPCSEA). Animals were maintained under well-regulated light-
dark (12 h:12 h) schedule at 26±2°C and fed with standard commercial 
laboratory chow along with tap water ad libitum.
Sample collection
After the acclimatization period of 1 week, the animals were fasted 
overnight and sacrificed on the next day by subjecting them to high 
ether anesthesia. Cranium and abdominal cavity of mice were opened 
carefully, and brain as well as liver samples were dissected out. Tissues 
were washed in cold normal saline, blotted dry, and subjected to the 
process of homogenization.
Preparation of tissue homogenates
Nearly 2% tissue homogenates of each of fresh brain and liver were 
prepared separately in chilled double distilled water for estimation 
of protein contents while 10% tissue homogenates were prepared 
in ice cold 0.1M phosphate buffer (pH=7.4) for estimation of lipid 
peroxidation.
Experimental design
The in vitro study experiment was divided into two separate phases. 
During the first phase, different doses of lead acetate were administered 
in mice brain and liver homogenate cultures to investigate the lead-
induced metabolic alterations in biochemical parameters. The 
second phase involved coadministration of specific dosage of lead 
acetate and synthetic antioxidants mixture as well as lead acetate 
and herbal antioxidant B. monnieri extract in homogenate cultures as 
per the experimental groups to investigate their ameliorative effect 
against lead toxicity. The dosage selection for lead acetate, synthetic 
antioxidants, and B. monnieri extract was based on standardization 
carried out in the laboratory using serial dilution technique to get 
effective concentrations for in vitro analysis and derived on the basis 
of extrapolation of available data from literature through calculation of 
organ weight ratio for mammalian tissues.
Experimental protocol
The mice brain and liver homogenates (1 ml) were divided into 
different experimental groups and exposed to different dosage of lead 
acetate, synthetic antioxidants mixture as well as ethanolic extract 
of B. monnieri separately for duration of 1-h in experimental tubes at 
37°C in BOD incubator containing 5% CO2 for estimation of biochemical 
parameters.
Experimental groups




Synthetic antioxidants mixture exposed group
 (Brain culture: NAC-8 µg/ml + ascorbic acid-1.78 mg/ml + 
tocopheryl acetate-1.42 mg/ml + thiamine-0.3 mg/ml)
 (Liver culture: NAC-1.8 µg/ml + ascorbic acid-0.381 mg/ml + 
tocopheryl acetate-0.305 mg/ml + thiamine-57.1 µg/ml)
3. Group-III: A-II
Herbal antioxidant exposed group
 (B. monnieri extract- Brain culture: 0.1 mg/ml; Liver culture: 
0.1 mg/ml)
4. Group-IV: Low dose (LD)
Lead acetate LD (100 µM) exposed group
5. Group-V: Mid dose (MD)
Lead acetate MD (250 µM) exposed group
6. Group-VI: High dose (HD)
Lead acetate HD (500 µM) exposed group
7. Group-VII: HD + A-I
 Lead acetate (500 µM) and synthetic antioxidants mixture 
(coadministration) exposed group and
8. Group-VIII: HD + A-II




To evaluate the impact of lead acetate as well as synthetic and herbal 
antioxidants exposure on protein metabolism, level of soluble protein 
was determined in brain and liver homogenates by the standard 
method of Lowry et al. (1951) using alkaline copper solution and 
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Folin–Ciocalteu reagent [19]. The intensity of blue color developed 
was measured at 600 nm spectrophotometrically (Systronics 
ultraviolet [UV]-visible spectrophotometer 167). Protein levels were 
expressed as mg protein/100 mg fresh tissue weight.
Lipid peroxidation assay
For investigation of oxidative stress-inducing capacity of lead 
and antioxidative potential of synthetic and herbal antioxidants, 
lipid peroxidation was induced by the addition of H2O2 in the lead-
exposed tissue homogenates. The reaction mixtures containing 
tissue homogenates, sodium dodecyl sulfate, glacial acetic acid, and 
thiobarbituric acid were then heated at 80°C for 1-h in boiling water 
bath. After completion of the reaction, the samples were centrifuged 
at 1500 rpm for 15 min, and the optical density of the pink chromogen 
was recorded at 535 nm spectrophotometrically (Systronics UV-
visible spectrophotometer 167). Lipid peroxidation was determined 
by measurement of thiobarbituric acid reactive substances (TBARS) 
according to the standard method of Ohkawa et al. (1979) [20]. Lipid 
peroxidation was expressed in terms of nanomoles of malondialdehyde 
(MDA) produced/60 min/100 mg tissue weight.
Statistical analysis
The results data of in vitro study were expressed as mean ± standard 
error of the mean (SEM) for each parameter (n=5). Statistical analysis 
was performed using GraphPad Prism software, version 5.03. 
Comparison among different groups was made by one-way analysis of 
variance followed by Tukey’s post hoc test. The level of significance was 
accepted with p<0.05.
RESULTS
Effect of lead and antioxidants on the protein content of mice brain 
homogenates
Effect of lead acetate exposure on protein metabolism and its 
amelioration using synthetic and herbal antioxidants was evaluated 
in the in vitro condition in brain homogenate cultures. Exposure of 
brain homogenates to different concentrations (100 µM, 250 µM, and 
500 µM) of lead acetate showed a significant reduction in protein levels 
as compared to control group in a dose-dependent manner (R2=0.999) 
(Table 1). Results revealed that protein content statistically significantly 
(p<0.001) decreased as the concentration of lead acetate was increased 
as compared to control group (LD: 16.06%, MD: 34.28%, HD: 45.39%) 
(Table 2). Maximum decline (45.39%) in protein content was observed 
at 500 µM lead acetate exposure as compared to control. Results also 
emphasized that administration of mixture of synthetic antioxidants 
as well as ethanolic extract of B. monnieri separately (Groups VII and 
VIII) along with the highest concentration (500 µM) of lead in brain 
homogenate cultures statistically very significantly exerted protective 
effect against lead toxicity (p<0.001) through prevention of reduction 
in protein levels by showing the decline up to only 2.15% and 1.21%, 
respectively, as compared to control group and increase in protein 
levels by 79.19% and 80.89%, respectively, as compared to the high 
dose of lead acetate exposed group (Table 2).
Effect of lead and antioxidants on lipid peroxidation level of mice 
brain homogenates
For analyzing oxidative stress induced by lead acetate exposure and 
antioxidative as well as the neuroprotective potential of selected 
synthetic and herbal antioxidants, the amount of metabolic products 
of lipid peroxidation in the form of malondialdehyde as TBARS was 
measured in brain homogenate cultures. Exposure of mice brain 
homogenates to three different concentrations (100 µM, 250 µM, and 
500 µM) of lead acetate showed statistically significant (p<0.001) dose-
dependent (R2=0.998) increase in MDA levels (Table 1) as compared to 
control group (LD: 32.05%, MD: 84.10%, and HD: 149.52%) (Table 2). 
Maximum elevation in lipid peroxidation (149.52%) was obtained at 
500 µM concentration of lead acetate exposure. Administration of the 
mixture of synthetic antioxidants as well as B. monnieri ethanolic extract 
separately (Groups VII and VIII) along with highest lead concentration 
(500 µM) in brain homogenate cultures statistically very significantly 
Table 1: In vitro effect of lead and antioxidants on protein metabolism and oxidative stress indices of control and exposed mice brain 
homogenates
Group no Experimental groups Experimental parameters 
Protein levels mg/100 mg 
tissue wt.
Lipid peroxidation nano moles 
MDA/h/mg protein
Group-I Untreated control 3.959±0.006 796.087±4.006
Antidotes exposed groups
Group-II Synthetic antioxidants mixture (A-I) 3.964±0.004 782.601±2.457
Group-III Bacopa monnieri extract (A-II) 3.975±0.005 774.047±2.120
Toxin exposed groups
Group-IV Lead acetate low dose (100 µM) 3.323±0.007a* 1051.243±5.487a*
Group-V Lead acetate mid dose (250 µM) 2.602±0.004a* 1465.632±4.456a*
Group-VI Lead acetate high dose (500 µM) 2.162±0.005a* 1986.407±13.41a*
Toxin+Antidotes exposed groups
Group-VII Lead acetate high dose (500 µM) (HD) + (A-I) 3.874±0.007b* 835.470±7.674b*
Group-VIII Lead acetate high dose (500 µM) (HD) + (A-II) 3.911±0.002b* 811.229±3.837b*
([A-I] = NAC – 8 µg/ml+Ascorbic acid – 1.78 mg/ml+Tocopheryl acetate – 1.42 mg/ml+Thiamine – 0.3 mg/ml) ([A-II] =Bacopa monnieri – 0.1 mg/ml). *p<0.001. Values 
are expressed as mean±SEM; (n=5). aAs compared to control group; bas compared to toxin (high-dose lead acetate) exposed group (Group VI). No significant difference 
was noted between untreated control and antidotes control groups. SEM: Standard error of mean
Table 2: Gross effect of lead acetate and antioxidants on mice brain homogenate cultures in vitro (percentage of difference with respect 
to their control and high-dose lead-exposed groups)














1. Protein levels 16.06 34.28 45.39 2.15 1.21 79.19* 80.89*
2. Lipid peroxidation 32.05* 84.10* 149.52* 4.95* 1.90* 57.94 59.16
All values are expressed in percentage of decrease or *increase. aAs compared to control group. bAs compared to toxin (high-dose lead acetate) exposed 
Group-VI. LD = 100 µM lead acetate; MD = 250 µM lead acetate; HD = 500 µM lead acetate; (A-I) = (NAC-8 µg/ml + ascorbic acid-1.78 mg/ml + tocopheryl 
acetate-1.42 mg/ml + thiamine-0.3 mg/ml). (A-II) =Bacopa monnieri extract – 0.1 mg/ml
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(p<0.001) prevented the increase in MDA level up to 4.95% and 1.90% 
as compared to control group as well as reduced the levels of MDA 
by 57.94% and 59.16%, respectively, as compared to high-dose lead-
exposed group and exerted amelioration in oxidative stress induced by 
lipid peroxidation (Table 2).
Effect of lead and antioxidants on the protein content of mice liver 
homogenates
In vitro exposure of liver homogenate cultures to different 
concentrations (100 µM, 250 µM, and 500 µM) of lead acetate showed 
a significant reduction in protein levels as compared to control group 
(Table 3). Results revealed that protein content statistically significantly 
(p<0.001) decreased in a dose-dependent manner (R2=0.999) as the 
concentration of lead was increased with respect to control group (LD: 
12.40%, MD: 18.18%, and HD: 59.67%) (Table 4). Maximum decline in 
protein content was observed at 500 µM lead exposure (59.67%) as 
compared to the control group. Results also revealed that administration 
of mixture of synthetic antioxidants or ethanolic extract of B. monnieri 
to Group VII and Group VIII respectively along with the highest 
concentration (500 µM) of lead in liver homogenate cultures  imparted 
statistically very significant (p<0.001) protection against lead toxicity 
through prevention of reduction in protein levels as revealed by decline 
up to 11.41% and 10.23% respectively as compared to control group 
and increase in protein levels by 119.70% and 122.63% respectively as 
compared to high dose lead acetate exposed group (Table 4).
Effect of lead and antioxidants on lipid peroxidation level of mice 
liver homogenates
For determination of oxidative stress-inducing capacity of lead acetate 
and antioxidative as well as the hepatoprotective potential of selected 
synthetic and herbal antioxidants, the amount of metabolic products 
of lipid peroxidation in the form of MDAs was measured in liver 
homogenate cultures. Exposure of mice liver homogenate cultures to 
three different concentrations (100 µM, 250 µM, and 500 µM) of lead 
acetate in in vitro condition showed statistically significant (p<0.001) 
increase in MDA levels in a dose-dependent manner (R2=0.997) 
(Table 3) as compared to control group (LD: 48.31%, MD: 69.07%, 
and HD: 278.50%) (Table 4). Maximum lipid peroxidation (278.50%) 
was obtained at the 500 µM concentration of lead acetate exposure. 
Administration of the mixture of synthetic antioxidants as well as 
B. monnieri ethanolic extract separately (Groups VII and VIII) along 
with highest lead concentration (500 µM) in liver homogenate cultures 
statistically very significantly (p<0.001) reduced the levels of MDA by 
18.71% and 14.85% as compared to control group as well as 68.64% 
and 69.66%, respectively, as compared to high-dose lead-exposed 
group and exhibited amelioration against oxidative stress induced by 
lipid peroxidation (Table 4).
DISCUSSION
The present experimental study revealed that lead acetate exposure 
in vitro caused statistically extremely significant decrease in protein 
content of mice brain and liver homogenate cultures as compared to 
their respective controls. The principal reason for the reduction in 
protein content might be the interference of lead with –SH groups of 
enzyme systems essential to cellular metabolism [21,22]. Further 
MDA formed as by-products of lipid peroxidation might react with –SH 
groups of proteins and inhibit enzymes requiring –SH groups for their 
activities [23]. Lipid peroxidation products such as hydroperoxides can 
inhibit protein synthesis and alter chemotactic activity [24]. Lead has 
been reported to form mercaptides with thiol groups of cysteine and less 
stable complexes with other amino acid side chains [25]. In the present 
study, reduction obtained in protein levels aftermath lead exposure 
could be attributed to their damage by singlet oxygen, often due to 
oxidation of essential amino acids, especially, methionine, tryptophan, 
histidine, or cysteine residues. The alteration in protein content could 
be the outcome of lead-induced inhibition of protein biosynthesis, 
which might be the result increased level of proteolysis [26]. Lead 
has been reported to perturb protein biosynthesis in hepatocytes, 
including the structural proteins [27]. Lead toxicity has been reported 
to cause hemolysis and deamination of proteins [28]. Pb2+ perturbs 
intracellular Ca2+ homeostasis [29] leading to endoplasmic reticulum 
Table 3: In vitro effect of lead and antioxidants on protein metabolism and oxidative stress indices of control and exposed mice liver 
homogenates
Group no. Experimental groups Experimental parameters 
Protein levels mg/100 mg tissue wt. Lipid peroxidation nano moles 
MDA/h/mg protein
Group-I Untreated control 5.337±0.003 582.516±2.148
Antidotes exposed groups
Group-II Synthetic antioxidants mixture (A-I) 5.332±0.005 601.106±5.266
Group-III Bacopa monnieri extract (A-II) 5.342±0.003 593.932±2.710
Toxin exposed groups
Group-IV Lead acetate low dose (LD) (100 µM) 4.675±0.006a* 863.907±2.932a*
Group-V Lead acetate mid dose (MD) (250 µM) 4.367±0.005a* 984.853±5.654a*
Group-VI Lead acetate high dose (HD) (500 µM) 2.152±0.005a* 2204.855±25.69a*
Toxin antidotes exposed groups
Group-VII Lead acetate high dose (500 µM) (HD)+(A-I) 4.728±0.004b* 691.516±7.197b*
Group-VIII Lead acetate high dose (500 µM) (HD)+(A-II) 4.791±0.004b* 668.998±5.921b*
([A-I] = NAC-1.8 µg/ml+ascorbic acid-0.381 mg/ml+tocopheryl acetate – 0.305 mg/ml+thiamine – 57.1 µg/ml) ([A-II] =Bacopa monnieri – 0.1 mg/ml]
*p<0.001. Values are expressed as mean±SEM; (n=5). aAs compared to control group; bas compared to toxin (high-dose lead acetate) exposed group (Group VI). No 
significant difference was noted between untreated control and antidotes control groups. MDA: Malondialdehyde, SEM: Standard error of mean
Table 4: Gross effect of lead acetate and antioxidants on mice liver homogenate cultures in vitro (percentage of difference with respect 
to their control and high-dose lead-exposed groups)














1. Protein levels 12.40 18.18 59.67 11.41 10.23 119.70* 122.63*
2. Lipid peroxidation 48.31* 69.07* 278.50* 18.71 14.85 68.64 69.66
All values are expressed in percentage of decrease or *increase. aAs compared to control group, bAs compared to toxin (high-dose lead acetate) exposed Group – VI, 
LD=100 µM lead acetate; MD=250 µM lead acetate; HD=500 µM lead acetate; (A-I) = (NAC-8 µg/ml+ascorbic acid – 1.78 mg/ml+tocopheryl acetate – 1.42 mg/ml+ 
thiamine – 0.3 mg/ml). (A-II) =Bacopa monnieri extract – 0.1 mg/ml
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damage, which might, in turn, result in protein depletion. Thus, it is 
evident that the reduction in protein levels due to lead acetate exposure 
might subsequently lead to alteration in the structural and functional 
integrity of tissues. Hence, one of the principal reasons for lead-induced 
neurotoxicity and hepatotoxicity in the current study might be the lack 
of availability of proteins necessary for growth and differentiation of 
tissues and functioning of enzymatic systems. Our findings related 
to lead-induced reduction in protein levels also corroborate with the 
results of several scientific researchers [30-34].
The present in vitro study also revealed that lead acetate exposure 
caused statistically extremely significant increase in the end product 
of lipid peroxidation in the form of MDA in mice brain and liver 
homogenate cultures as compared to their respective controls. Lipid 
peroxidation is characterized by a deleterious process solely carried 
out by free radicals and manifestation of cellular deteriorative change 
resulting in oxidative stress generated physiological and biochemical 
alterations in the biological system [35].
One of the major reasons for lead-induced toxicity to mammalian 
tissues might be attributed to its ability to generate reactive oxygen 
species (ROS) leading to enhancement of complex mechanism of 
lipid peroxidation as the outcome of peroxidative chain events [36]. 
The underlying mechanism of lead toxicity involves stimulation of 
oxidative stress through enhancement of peroxidation of membrane 
lipids [37,38]. Enhanced oxidative stress is also evidenced by the 
accumulation of MDA such as by-products generated during the 
interaction of pro-oxidants and membrane lipids [39]. Most significant 
consequence of peroxidation of membrane lipids includes inactivation 
of cellular constituents by oxidation or induction of oxidative damage 
through free radical chain reaction mediated loss of membrane 
integrity [40] and alteration in fatty acid composition [3] leading 
to increase in cell membrane permeability [41] and influx of Ca+2 
causing further mitochondrial damage [42]. Lead exposure is known 
to directly interrupt activation of enzymes, inhibit trace mineral 
absorption competitively, prevent protein synthesis through binding of 
the sulfhydryl groups, and alter calcium homeostasis [43]. Activation 
of free radical-mediated deleterious processes and impairment of the 
antioxidant defense system are recognized as the principal mechanisms 
involved in the pathophysiology associated with lead intoxication [44]. 
Lead toxicity tends to decrease the level of reduced glutathione and 
activities of antioxidant enzymes due to its high affinity for -SH group or 
metal cofactor in these enzymes which further contributes to rise in free 
radicals ultimately leading to enhanced lipid peroxidation [32,45,46]. 
Many researchers have reported the role of oxidative stress in lead-
induced toxicity in support of our data [47-49].
Brain is believed to be the most vulnerable organ to encounter lead-
induced oxidative stress leading to neurotoxicity as it has the capacity 
to generate a high rate of oxygen free radicals without commensurate 
levels of antioxidant defenses [50]. It was reported that lead increased 
the level of brain TBARS leading to lipid peroxidation [51] and altered 
the antioxidant defense system [6]. Sandhir and Gill (1995) have 
reported similar effects in the hepatic tissues also [21]. Generation of 
highly ROS and lipid peroxides aftermath lead-exposure might result 
in systemic mobilization and depletion of cells intrinsic antioxidant 
defense rendering the tissue more susceptible to free radical injury. 
In vitro participation of ROS and oxidative stress in plumbism appears 
to be supported by our observations of amplified lipid peroxidation 
in mice brain and liver homogenates and provides further evidence 
to dysregulation of pro-oxidant/antioxidant balance aftermath lead 
exposure. Many in vitro and in vivo studies have also reported marked 
enhancement in MDA levels in the lead-exposed liver, brain, and red 
blood cells which support our findings [10,38,43,52-55]. Rise in lipid 
peroxidation due to lead exposure had also been demonstrated in 
heart, kidney, and other organs [56,57]. Several recent studies had also 
confirmed the possible involvement of an increased amount of ROS in 
lead-exposed animals for elevated MDA levels due to direct peroxidative 
activity [10,58-60].
In the current study, coadministration of lead and synthetic or herbal 
antioxidants to brain and liver homogenates in vitro significantly 
prevented elevation in MDA levels due to lipid peroxidation. Increase in 
TBARS due to lead administration was found to be reduced after vitamin 
supplementation with Vitamin C and Vitamin E [61]. Pande et al. (2001) 
also demonstrated a reduction in MDA levels by supplementation 
of antioxidants [62]. B. monnieri has been reported to possess anti-
peroxidative properties [63]. All these evidences corroborate with our 
findings.
In the present study, coadministration of synthetic antioxidants mixture 
or ethanolic extract of B. monnieri in high-dose lead-exposed mice 
brain and liver homogenates in vitro revealed statistically significant 
protection against reduction in protein contents. Selected synthetic and 
herbal antioxidants might be able to prevent cell injury by maintaining 
sulfhydryl groups of membrane binding proteins. It may be possible 
that compounds such as N-acetyl cysteine imparted some protection 
by providing additional -SH groups and maintaining glutathione level 
in tissues against the deleterious action of lead. Dreyfus (1985) had 
reported that vitamins could prevent the oxidation of -SH groups during 
lipid peroxidation [64]. The maintenance of protein in synthetic and 
herbal antioxidants exposed mice brain and liver homogenates might 
also be credited to their protective action against -SH group oxidation.
The results of the current study also emphasized that coadministration 
of synthetic antioxidants or B. monnieri extract in the lead-exposed 
cultures significantly ameliorated lead-induced elevation in lipid 
peroxidation. The ameliorative action might be attributed to free 
radical scavenging effect and inhibition of chain reaction by synthetic 
antioxidants mixture and B. monnieri ethanolic extract as well as 
degradation of reactive aldehyde generating lipid hydroperoxides, 
thereby protecting the integrity of plasma membrane.
Neuroprotective, hepatoprotective as well as membrane stabilizing 
properties of selected synthetic antioxidants mixture and herbal 
antioxidant B. monnieri might be attributed to their free radicals 
scavenging ability, metal chelating property, ability to reduce cell protein 
necrosis and potential to reduce glutathione depletion. Prevention in 
the reduction of protein content in the lead-exposed homogenates by 
selected antidotes might be the result of the restoration of the energy 
status of the selected tissues.
Mechanism of action of synthetic antioxidants is seemed to be mainly by 
virtue of detoxification due to their capacity to act as powerful reducing 
agents and the ability to scavenge ROS. N-acetyl cysteine exhibited 
antioxidant capacity against lead toxicity through maintaining intracellular 
glutathione levels and scavenging free radicals [48]. Ascorbic acid is well 
known to terminate propagation of peroxidation process by acting as 
chain-breaking antioxidant [65]. Ascorbic acid has also been reported to 
restore and recycle antioxidative properties of Vitamin E and glutathione, 
when attacked by pro-oxidants [10,66]. Vitamin E is believed to be nature’s 
key lipid-soluble antioxidant with peroxidation chain-breaking ability, 
and tocopheryl acetate is the most bioactive form of it. Vitamin E is well 
known to exert a protective effect against oxidative stress to biological 
membranes and lipoproteins [67]. The proposed mechanism of thiamine 
in alleviating lead toxicity might be attributed to its capacity to form a 
complex with lead metal leading to its excretion. Anna and Wiglo (2006) 
also had reported that thiamine could act as a potent antioxidant due to its 
capability to scavenge free radicals [68]. Hence, it can be interpreted that 
the correct combination of selected synthetic antioxidants in a mixture 
has the capacity to counteract lead-induced toxicity in mammals.
Medicinal herb B. monnieri possesses remarkable antioxidant properties 
as denoted by its ability to scavenge superoxide ions, peroxides, and 
hydroxyl radicals [69,70]. It has also been found to involve in the 
modulation of expression of enzymes associated with ROS scavenging 
activities [71]. Principle mode of action of B. monnieri includes chelation 
of metal ions, breaking of oxidative chain reaction [72], and improvement 
in activities of antioxidative defense enzymes [73]. Phytochemical 
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screening of B. monnieri extract has revealed the presence of numerous 
pharmacologically active constituents comprising phenolics, flavonoids, 
alkaloids, saponins, and steroids [74,75]. These phytochemicals can 
act as powerful reducing agents, hydrogen donors, and singlet oxygen 
quenchers thereby imparting antioxidant property to the plant extract. 
Neuroprotective ability, hepatoprotective activity, and antioxidant 
potential of B. monnieri ethanolic extract might be attributed to the 
occurrence of its characteristic dammarane-type pharmacologically 
active constituent triterpenoid saponin termed as “Bacopside-A” [76].
Thus, synthetic antioxidants and B. monnieri exerted protection 
against lead toxicity-induced metabolic dysfunctions by virtue of their 
oxidative stress reducing potential through prevention of enhancement 
in lipid peroxidation and subsequent maintenance of protein levels in 
mice brain and liver homogenate cultures.
CONCLUSION
Outcomes of the present toxicological study clearly emphasized 
that lead-exposure adversely exaggerated biochemical indices of 
mammalian brain and liver through alterations in protein content and 
lipid peroxidation in vitro and ascertained that lead metal has definitely 
destructive effect on the metabolic and functional status of mammalian 
vital organs through induction of neurotoxicity and hepatotoxicity. 
The underlying mechanism of action for lead toxicity-induced 
metabolic dysfunctions encompassed excessive generation of ROS, and 
enhancement of lipid peroxidation mediated oxidative stress which 
might have resulted into alteration in cell membrane permeability and 
structural proteins through oxidization of membrane -SH groups.
Findings of the present synergistic study also revealed that 
co-supplementation of lead acetate and synthetic antioxidants 
mixture as well as lead acetate and ethanolic extract of B. monnieri 
in vitro significantly exerted protection against deleterious effects 
of lead intoxication. Neuroprotective and hepatoprotective potential 
of selected synthetic and herbal antidotes might be attributed to 
their anti-peroxidative, metal chelating, detoxifying, and antioxidant 
properties. Present investigation also revealed the greater ameliorative 
potential of the ethanolic extract of B. monnieri against lead toxicity-
induced metabolic dysfunctions as compared to synthetic antioxidants 
mixture which could be credited to the synergistic action of plentiful 
pharmacologically active phytochemicals present in the extract.
Present research investigation holds a special significance in the field 
of pharmaceutical research as it has explored very effective antidotes 
in the form of novel combination of synthetic antioxidants mixture and 
B. monnieri as beneficiary ameliorative agents for the eradication of lead 
toxicity world over. The findings of the present study would be of immense 
contribution in the arena of occupational toxicology for attaining better 
clinical recoveries in lead intoxication cases encompassing altered 
protein and lipid metabolism through designing of new, safe, and highly 
effective therapeutic strategies using antioxidants.
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